References

Panel testing for the molecular genetic diagnosis of congenital hypogonadotropic hypogonadism—a clinical perspective

10.1038/s41431-022-01261-0 · 2023 · External reference

Hypogonadisme hypogonadotrope: notions récentes sur la régulation de l'axe hypothalamo‐hypophyso‐gonadique

10.1016/s0003-4266(10)70005-6 · 2010 · External reference

European consensus statement on congenital hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment

10.1038/nrendo.2015.112 · 2015 · External reference

Congenital hypogonadotrophic hypogonadism: Minipuberty and the case for neonatal diagnosis

10.3389/fendo.2019.00097 · 2019 · External reference

Mini‐puberty, physiological and disordered: consequences, and potential for therapeutic replacement

10.1210/endrev/bnae003 · 2024 · External reference

Congenital hypogonadotropic hypogonadism: implications of absent mini‐puberty

2016 · External reference

Gonadotropin therapy for mini‐puberty induction in male infants with hypogonadotropic hypogonadism

10.1210/clinem/dgae874 · 2025 · External reference

Gonadotropin administration to mimic mini‐puberty in hypogonadotropic males: pump or injections?

10.1530/ec-22-0252 · 2023 · External reference

Genetics in endocrinology: genetic counseling for congenital hypogonadotropic hypogonadism and Kallmann syndrome: new challenges in the era of oligogenism and next‐generation sequencing

10.1530/eje-17-0749 · 2018 · External reference

Molecular genetic diagnostics of hypogonadotropic hypogonadism: from panel design towards result interpretation in clinical practice

10.1007/s00439-020-02148-0 · 2021 · External reference

Clinical management of congenital hypogonadotropic hypogonadism

10.1210/er.2018-00116 · 2019 · External reference

The candidate gene for the X‐linked Kallmann syndrome encodes a protein related to adhesion molecules

10.1016/0092-8674(91)90193-3 · 1991 · External reference

Genetic analysis of patients with congenital hypogonadotropic hypogonadism: a case series

10.3390/ijms24087428 · 2023 · External reference

A family with hypogonadotropic hypogonadism and mutations in the gonadotropin‐releasing hormone receptor

10.1056/nejm199711273372205 · 1997 · External reference

Loss‐of‐function mutations in FGFR1 cause autosomal dominant Kallmann syndrome

10.1038/ng1122 · 2003 · External reference

Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes

10.1016/j.mce.2006.04.021 · 2006 · External reference

Congenital hypogonadotropic hypogonadism during childhood: presentation and genetic analyses in 46 boys

10.1371/journal.pone.0077827 · 2013 · External reference

The genetic backdrop of hypogonadotropic hypogonadism

10.3390/ijms222413241 · 2021 · External reference

Phenotype and genotype of 23 patients with hypopituitarism and pathogenic GLI2 variants

10.1093/ejendo/lvaf015 · 2025 · External reference

Genetics of combined pituitary hormone deficiency: roadmap into the genome era

10.1210/er.2016-1101 · 2016 · External reference

Unresolved reference

External reference

Additional mutation in PROKR2 and phenotypic differences in a Kallmann syndrome/normosmic congenital hypogonadotropic hypogonadism family carrying FGFR1 missense mutation

10.1136/bcr-2023-258042 · 2024 · External reference

Clinical lessons learned in constitutional hypopituitarism from two decades of experience in a large international cohort

10.1111/cen.14355 · 2021 · External reference

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

10.1038/gim.2015.30 · 2015 · External reference

MobiDetails: online DNA variants interpretation

10.1038/s41431-020-00755-z · 2021 · External reference

Small vulnerable newborns—big potential for impact

10.1016/s0140-6736(23)00354-9 · 2023 · External reference

Macrosomia: ACOG practice bulletin, number 216

10.1097/aog.0000000000003606 · 2020 · External reference

The external genitalia score (EGS): a European multicenter validation study

10.1210/clinem/dgz142 · 2020 · External reference

A normative model of serum inhibin B in Young males

10.1371/journal.pone.0153843 · 2016 · External reference

Paediatric anti‐Müllerian hormone measurement: male and female reference intervals established using the automated Beckman coulter access AMH assay

10.1002/edm2.21 · 2018 · External reference

Diagnosis of endocrine disease: pituitary stalk interruption syndrome: etiology and clinical manifestations

10.1530/eje-19-0168 · 2019 · External reference

New genetic findings in a large cohort of congenital hypogonadotropic hypogonadism

10.1530/eje-18-0764 · 2019 · External reference

Comprehensive molecular studies in 88 Japanese patients with congenital hypogonadotropic hypogonadism

10.1210/clinem/dgaf548 · 2025 · External reference

Targeted gene panel sequencing for molecular diagnosis of Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism

10.1055/a-0681-6608 · 2019 · External reference

Reproductive phenotypes and genotypes in men with IHH

10.1210/clinem/dgac615 · 2023 · External reference

Identification of gene variants in a cohort of hypogonadotropic hypogonadism: diagnostic utility of custom NGS panel and WES in unravelling genetic complexity of the disease

10.1016/j.mce.2020.110968 · 2020 · External reference

Prevalence of pathogenic variants and digenic disease in patients diagnosed with normosmic hypogonadotropic hypogonadism/Kallmann syndrome

10.1016/j.mce.2024.112224 · 2024 · External reference

Prevalence and phenotypic effects of copy number variants in isolated hypogonadotropic hypogonadism

10.1210/clinem/dgac300 · 2022 · External reference

FSH and Sertoli cell biomarkers accurately distinguish hypogonadotropic hypogonadism from self‐limited delayed puberty

10.1210/clinem/dgaf062 · 2025 · External reference

Distinguishing constitutional delay of growth and puberty from isolated hypogonadotropic hypogonadism: critical appraisal of available diagnostic tests

10.1210/jc.2012-1598 · 2012 · External reference

Inhibin B and AMH for diagnosis of hypogonadotropic hypogonadism in boys under 1 year of age: a case‐control study

10.1210/clinem/dgaf219 · 2025 · External reference

Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutations

10.1371/journal.pone.0025614 · 2011 · External reference

TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for neurokinin B in the central control of reproduction

10.1038/ng.306 · 2009 · External reference

TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans

10.1210/jc.2009-2600 · 2010 · External reference

Hypogonadotropic hypogonadism due to compound heterozygous mutations TACR3 in siblings

10.1002/ccr3.3370 · 2020 · External reference

TAC3/TACR3 mutations reveal preferential activation of gonadotropin‐releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood

10.1210/jc.2009-2320 · 2010 · External reference

The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome

10.1016/j.fertnstert.2011.09.046 · 2011 · External reference

Expanding the Spectrum of founder mutations causing isolated gonadotropin‐releasing hormone deficiency

10.1210/jc.2015-2262 · 2015 · External reference

Congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty have distinct genetic architectures

10.1530/eje-17-0568 · 2018 · External reference

Expanding the mutational spectrum of monogenic hypogonadotropic hypogonadism: novel mutations in ANOS1 and FGFR1 genes

10.1186/s12958-020-0568-6 · 2020 · External reference

Congenital hypogonadotropic hypogonadism with split hand/foot malformation: a clinical entity with a high frequency of FGFR1 mutations

10.1038/gim.2014.166 · 2015 · External reference

Comparative functional analysis of two fibroblast growth factor receptor 1 (FGFR1) mutations affecting the same residue (R254W and R254Q) in isolated hypogonadotropic hypogonadism (IHH)

10.1016/j.gene.2012.12.041 · 2013 · External reference

Kallmann syndrome

10.1038/ejhg.2008.206 · 2009 · External reference

FGFR1 analyses in four patients with hypogonadotropic hypogonadism with Split‐hand/foot malformation: implications for the promoter region

10.1002/humu.23178 · 2017 · External reference

GnRH deficient patients with congenital hypogonadotropic hypogonadism: novel genetic findings in ANOS1, RNF216, WDR11, FGFR1, CHD7, and POLR3A genes in a case series and review of the literature

10.3389/fendo.2020.00626 · 2020 · External reference

Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and Septo‐optic dysplasia

10.1210/jc.2011-2938 · 2012 · External reference

Identification of genetic variants and phenotypic characterization of a large cohort of patients with congenital hypopituitarism and related disorders

10.1016/j.gim.2023.100881 · 2023 · External reference

Combined pituitary hormone deficiency in a patient with an FGFR1 missense variant: case report and literature review

10.1297/cpe.2022-0020 · 2022 · External reference

A nonsense variant in FGFR1: a rare cause of combined pituitary hormone deficiency

10.1515/jpem-2020-0029 · 2020 · External reference

SOX11 variants cause a neurodevelopmental disorder with infrequent ocular malformations and hypogonadotropic hypogonadism and with distinct DNA methylation profile

10.1016/j.gim.2022.02.013 · 2022 · External reference

Expanding the Spectrum of Endocrine abnormalities associated with SOX11 ‐related disorders

10.1210/clinem/dgae620 · 2025 · External reference

Ablation of the Sox11 gene results in Clefting of the secondary palate resembling the Pierre Robin sequence

10.1074/jbc.m115.690875 · 2016 · External reference

Loss‐of‐function mutations in SOX10 cause Kallmann syndrome with deafness

10.1016/j.ajhg.2013.03.024 · 2013 · External reference

Phenotypic continuum between Waardenburg syndrome and idiopathic hypogonadotropic hypogonadism in humans with SOX10 variants

10.1038/s41436-020-01051-3 · 2021 · External reference

10.1056/nejmra2305989

10.1056/nejmra2305989 · External reference

Timing of orchidopexy and its relationship to postoperative testicular atrophy: results from the ORCHESTRA study

10.1093/bjsopen/zraa052 · 2021 · External reference

Evaluation and treatment of cryptorchidism: AUA guideline

10.1016/j.juro.2014.05.005 · 2014 · External reference

Management of undescended testes: European Association of Urology/European Society for Paediatric Urology Guidelines

10.1016/j.jpurol.2016.07.014 · 2016 · External reference

Surgical treatment of cryptorchidism: current insights and future directions

10.3389/fendo.2024.1327957 · 2024 · External reference

Effect of pubertal induction with combined gonadotropin therapy on testes development and spermatogenesis in males with gonadotropin deficiency: a cohort study

10.1093/hropen/hoaf026 · 2025 · External reference

Evaluating CHARGE syndrome in congenital hypogonadotropic hypogonadism patients harboring CHD7 variants

10.1038/gim.2017.197 · 2018 · External reference